We help build biotechnology and pharmaceutical patent portfolios through strategic patent preparation and prosecution. We have significant experience and expertise in providing patent prosecution services to a wide range of biotech and pharmaceutical companies, from innovative start-ups to some of the largest companies in the world.
Our patent group works closely with our clients to develop patent estates for protecting innovations worldwide. We also help clients analyze patents, guide them in navigating patent landscapes, and assist in patent licensing. We also perform IP due diligence for clients’ business investments.
We have assisted pharmaceutical and biotechnology companies with securing patent protection in a variety of technical areas, including:
- Biologics
- Small molecule drugs
- RNA therapeutics
- Vaccines
- Lipid nanoparticles
- Gene editing
- Epigenetic regulation
- Gene therapy
- Immune cell therapy
- Regenerative cell therapy
Noteworthy
- Chambers USA, Intellectual Property: Patent, New York (2022-2023)
- China Law & Practice, Shortlisted, Intellectual Property Firm of the Year (2021-2022)
- China Business Law Journal, China Business Law Award: IP (Patent) (2018-2022)
- IAM 1000, United States: New York, Patent Prosecution, Bronze (2019-2023)
- China Law & Practice, International Firm of the Year: Intellectual Property (2020)
Representative Matters
- We assist Sanofi, including its subsidiaries Genzyme and Sanofi Pasteur, with preparation and worldwide prosecution of patent applications, including on clinical-stage products. We work with a network of foreign agents in international prosecution, with us coordinating prosecution strategies. We provide patent landscape analysis; noninfringement and invalidity analysis; and patent portfolio management and strategic advice. We also assist the client in IP due diligence.
- We assist Laboratoires Servier, including its Danish subsidiary Symphogen A/S, with preparation and worldwide prosecution of patent applications. We provide patent portfolio management and strategic advice.
- We assist Lyell Immunopharma with preparation and worldwide prosecution of patent applications. We provide patent landscape analysis, as well as patent portfolio management and strategic advice. We also assist the client in IP due diligence.
- We assist Regeneron Pharmaceuticals in IP due diligence in connection with its transactions. We also provide patent invalidity analysis.
- We assist Gilead Science in IP due diligence in connection with its transactions. We also provide patent landscape analysis.
- We also work with a number of startup companies and help them develop and manage their patent assets. One example is VelosBio, which was acquired by Merck for $2.8 billion.
News & Publications
Press Releases
July 20, 2023
Publications
A Comprehensive Overview of PTAB Trends for Biologics
June 26, 2023
By: Michael I. Green, Yun Zhang, Lawrence Kass, John J. Molenda, Ph.D.
Client Alerts
May 26, 2023
Press Releases
May 10, 2023
Press Releases
Asian Legal Business Names Timothy Bickham to Top 15 IP Lawyers List
February 22, 2023
Press Releases
Four Steptoe Lawyers Named to Lawyers of Color Law Firm Leaders Issue 2022
February 2, 2023